Monday, 19 October 2026European Markets
ExploreSearch
ViaNews EU
stockMarket

AUGROS COSMETICS Stock Was Up By 15.94% On Monday

Loading stream...

(vianews) - the market ended the session with augros cosmetics (augr.pa) jumping 15.94% to €8.00 on monday while cac 40 dropped 0.96% to €7,200.91.

about augros cosmetics

augros cosmetic packaging sa provides customized packaging solutions in france. the company offers decoration solutions for glass, plastic, and aluminum packaging materials. it serves the perfume, cosmetic, and spirit industries. the company is based in alencon, france. augros cosmetic packaging sa operates as a subsidiary of famille bourgine.

earnings per share

as for profitability, augros cosmetics has a trailing twelve months eps of €0.45.

pe ratio

augros cosmetics has a trailing twelve months price to earnings ratio of 17.78. meaning, the purchaser of the share is investing €17.78 for every euro of annual earnings.

volume

today's last reported volume for augros cosmetics is 10 which is 94.97% below its average volume of 199.

more news about augros cosmetics (augr.pa).

Categories

stockMarket

Tags

Market-Close NowStock PriceAUGROS COSMETICSClosesStock Market NowEnd of DayPrice UpMarket CloseStock Price UpStock MarketStockAUGR.PA
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Sovereign, Local and Open AI: Infrastructure and Applied Intelligence Scale Up While Frontier-Lab Safety Scrutiny Grows
AI is shifting from cloud-rented models toward locally run, owned and open intelligence. ASUS/NVIDIA RTX Spark laptops pair with Nous Research's Hermes and ComfyUI, and Microsoft pushes hybrid local/cloud Windows. Cisco, NVIDIA and Marvell build open high-bandwidth AI infrastructure, and Hesai supplies real-world data for physical AI. In finance and commerce, Intuit, Zeta, Parloa/TELUS Digital and Snipp embed agentic AI into trusted financial and customer workflows, while OpenAI's math breakthroughs, its security disclosures and an executive's departure from its safety role keep safety and governance scrutiny high.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,397 source documents archived
Query this data → isubstrate.com